Effect of combined gliclazide/metformin treatment on oxidative stress, lipid profile, and hepatorenal functions in type 2 diabetic patients
Background: Type 2 diabetes is a chronic condition that requires pharmacotherapy interventions. Metformin and gliclazide are widely used drugs in monotherapy. However, their complementary action made utilization of the combination of these drugs an appealing approach. Aims: The study compared major...
Main Authors: | Mansour Alsharidah, Metab. Algeffari, Abdel-Moneim Hafez Abdel-Moneim, Mohamed Faisal Lutfi, Haila Alshelowi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-01-01
|
Series: | Saudi Pharmaceutical Journal |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1319016417302025 |
Similar Items
-
Attenuation of lipid peroxidation and atherogenic factors in diabetic patients treated with gliclazide and metformin
by: Sujan Banik, et al.
Published: (2018-01-01) -
Thymoquinone, but Not Metformin, Protects against Gentamicin-Induced Nephrotoxicity and Renal Dysfunction in Rats
by: Mansour Alsharidah, et al.
Published: (2021-04-01) -
Thymoquinone Lowers Blood Glucose and Reduces Oxidative Stress in a Rat Model of Diabetes
by: Mohamed Faisal Lutfi, et al.
Published: (2021-04-01) -
Valsartan in combination with metformin and gliclazide in diabetic rat model using developed RP-HPLC method
by: Rasmita Patra, et al.
Published: (2021-08-01) -
Painful diabetic peripheral neuropathy among Saudi diabetic patients is common but under-recognized: Multicenter cross-sectional study at primary health care setting
by: Metab A Algeffari
Published: (2018-01-01)